BioCryst Pharmaceuticals, Inc. (BCRX) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Chris leonard Chris leonard 02/17/2016 1 Year $1.86 $6.16 +231.18% 231 Ended
Comments: BCRX has gotten beaten down after failed trial. this moved like crazy with the ebola crisis now zika
ddelov ddelov 09/04/2013 3 months $6.67 $6.32 -5.25% 5 Ended
Comments: It's too early for such optimistic valuation
riwan.bourse riwan.bourse 05/06/2013 1 month $1.89 $5.37 +184.13% 184 Ended
Comments: MM30 and Volumes of course
JOKER66 JOKER66 04/08/2013 1 day $1.70 $1.75 +2.94% 2 Ended
Dr. Stone Dr. Stone 04/07/2013 1 Year $1.70 $9.10 +435.29% 435 Ended
Comments: I think (NASDAQ:BOTA) Better !
B1capital B1capital 11/01/2012 3 months $2.56 $5.37 +109.77% 109 Ended
ibnahurry ibnahurry 05/24/2010 3 months N/A Ended
Comments: ,Several drugs in late stage clinical trials. Positive indicators on all. Peramivir already approved in Japan. Risk-reward is very favorable to upside.
Rico11_2 Rico11_2 01/12/2010 3 months N/A Ended

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.